MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride (Q40877845)

24 September 2017

MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride (English)

1 reference

24 September 2017

P Martin

1

1 reference

24 September 2017

N Waters

2

1 reference

24 September 2017

S Waters

3

1 reference

24 September 2017

A Carlsson

4

1 reference

24 September 2017

M L Carlsson

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

European Journal of Pharmacology

24 September 2017

1 reference

24 September 2017

335

1 reference

24 September 2017

2-3

1 reference

24 September 2017

107-116

1 reference

The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

The current status of the dopamine hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Dopamine receptors: molecular biology, biochemistry and behavioural aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Presynaptic dopaminergic modulation of cortical input to the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Neurons expressing 5-HT2 receptors in the rat brain: neurochemical identification of cell types by immunocytochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Phencyclidine- and Dizocilpine-Induced Hyperlocomotion Are Differentially Mediated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

The role of 5-HT2A receptors in antipsychotic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

MK-801-induced stereotypy and its antagonism by neuroleptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901188-6

10.1016/S0014-2999(97)01188-6

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference